Clinical Trial Detail

NCT ID NCT02920008
Title Phase 3 Randomized, Open-Label Study of Guadecitabine vs Treatment Choice in Previously Treated Acute Myeloid Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Astex Pharmaceuticals
Indications

acute myeloid leukemia

Therapies

Decitabine

Azacitidine

Cytarabine

Guadecitabine

Age Groups: adult senior

No variant requirements are available.